BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 12124803)

  • 1. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.
    Lecomte T; Berger A; Zinzindohoué F; Micard S; Landi B; Blons H; Beaune P; Cugnenc PH; Laurent-Puig P
    Int J Cancer; 2002 Aug; 100(5):542-8. PubMed ID: 12124803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
    Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors.
    Lin JK; Lin PC; Lin CH; Jiang JK; Yang SH; Liang WY; Chen WS; Chang SC
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S680-6. PubMed ID: 24841357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.
    Ryan BM; Lefort F; McManus R; Daly J; Keeling PW; Weir DG; Kelleher D
    Gut; 2003 Jan; 52(1):101-8. PubMed ID: 12477769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of circulating mutant DNA in unresectable metastatic colorectal cancer.
    Lefebure B; Charbonnier F; Di Fiore F; Tuech JJ; Le Pessot F; Michot F; Michel P; Frebourg T
    Ann Surg; 2010 Feb; 251(2):275-80. PubMed ID: 20010083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating free tumor DNA and colorectal cancer.
    Lecomte T; Ceze N; Dorval E; Laurent-Puig P
    Gastroenterol Clin Biol; 2010 Dec; 34(12):662-81. PubMed ID: 20832215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases.
    Trevisiol C; Di Fabio F; Nascimbeni R; Peloso L; Salbe C; Ferruzzi E; Salerni B; Gion M
    Int J Biol Markers; 2006; 21(4):223-8. PubMed ID: 17177160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
    Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival.
    Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Wu MS; Wang SM; Lin JT; Cheng AL
    Oncology; 1999; 57(2):149-56. PubMed ID: 10461063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MGMT promoter methylation and field defect in sporadic colorectal cancer.
    Shen L; Kondo Y; Rosner GL; Xiao L; Hernandez NS; Vilaythong J; Houlihan PS; Krouse RS; Prasad AR; Einspahr JG; Buckmeier J; Alberts DS; Hamilton SR; Issa JP
    J Natl Cancer Inst; 2005 Sep; 97(18):1330-8. PubMed ID: 16174854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer.
    Sefrioui D; Sarafan-Vasseur N; Beaussire L; Baretti M; Gangloff A; Blanchard F; Clatot F; Sabourin JC; Sesboüé R; Frebourg T; Michel P; Di Fiore F
    Dig Liver Dis; 2015 Oct; 47(10):884-90. PubMed ID: 26160500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
    Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J
    Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer.
    Sorenson GD
    Clin Cancer Res; 2000 Jun; 6(6):2129-37. PubMed ID: 10873061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients.
    An Q; Liu Y; Gao Y; Huang J; Fong X; Li L; Zhang D; Cheng S
    Cancer Lett; 2002 Dec; 188(1-2):109-14. PubMed ID: 12406555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating free DNA in a screening program for early colorectal cancer detection.
    Perrone F; Lampis A; Bertan C; Verderio P; Ciniselli CM; Pizzamiglio S; Frattini M; Nucifora M; Molinari F; Gallino G; Gariboldi M; Meroni E; Leo E; Pierotti MA; Pilotti S
    Tumori; 2014; 100(2):115-21. PubMed ID: 24852853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients.
    Domínguez G; Carballido J; Silva J; Silva JM; García JM; Menéndez J; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2002 Apr; 8(4):980-5. PubMed ID: 11948103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
    Chang SC; Lin JK; Lin TC; Liang WY
    Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer].
    Bai YQ; Liu XJ; Wang Y; Ge FJ; Zhao CH; Fu YL; Lin L; Xu JM
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):666-71. PubMed ID: 24332053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.
    Herbst A; Vdovin N; Gacesa S; Ofner A; Philipp A; Nagel D; Holdt LM; Op den Winkel M; Heinemann V; Stieber P; Graeven U; Reinacher-Schick A; Arnold D; Ricard I; Mansmann U; Hegewisch-Becker S; Kolligs FT
    Int J Cancer; 2017 May; 140(9):2134-2144. PubMed ID: 28124380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16INK4a methylation in serum as a follow-up marker for recurrence of colorectal cancer.
    Nakayama G; Kodera Y; Ohashi N; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2011 May; 31(5):1643-6. PubMed ID: 21617221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.